Status:
COMPLETED
Ischemia-reperfusion Exercise Study
Lead Sponsor:
University of Copenhagen
Conditions:
Insulin Sensitivity
Eligibility:
MALE
25-35 years
Phase:
NA
Brief Summary
The study investigates the relationship between activation of AMP-activated protein kinase (AMPK) in human skeletal muscle and the subsequent improvement in muscle insulin sensitivity for the stimulat...
Detailed Description
This study aims to demonstrate the association between AMPK activation and increased insulin sensitivity in human skeletal muscle. The investigators intend to examine insulin sensitivity after various...
Eligibility Criteria
Inclusion
- normal weight (BMI: below or equal to 27)
- physical active on a regular basis
- cardiorespiratory fitness between 40-60 ml/kg/min
- no history or sign of type 2 diabetes, hypertension, insulin resistance or dyslipidemia
Exclusion
- smoker
- BMI: above 27
- using any kind of medication
Key Trial Info
Start Date :
August 31 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 3 2020
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04872426
Start Date
August 31 2018
End Date
January 3 2020
Last Update
January 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Exercise, Nutrition and Sports, Faculty of Sciences, University of Copenhagen
Copenhagen, Denmark, 2100